Tech Company Financing Transactions
Nfinite Nanotechnology Funding Round
On 5/14/2024, Nfinite Nanotechnology received $6.5 million in Seed funding from Collateral Good, FTW Ventures and MaRS Investment Accelerator Fund.
Transaction Overview
Company Name
Announced On
5/14/2024
Transaction Type
Venture Equity
Amount
$6,500,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to scale operations, enhance R&D capabilities, and solidify market position as pioneers in eco-friendly packaging.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
265 Frobisher Drive, Unit 1
Waterloo, Ontario, N2V 2G4
Canada
Waterloo, Ontario, N2V 2G4
Canada
Phone
Undisclosed
Website
Email Address
Overview
Nfinite is a spin-out from the Functional Nanomaterials Lab at the University of Waterloo (Canada), led by Dr. Kevin Musselman, a global pioneer in Spatial Atomic Layer Deposition (SALD). Over the past 20 years, Dr. Musselman has advanced SALD through dozens of peer-reviewed publications, building the scientific foundation that makes Nfinite unique: a company rooted in rigorous academic research, now bringing proven nanotechnology out of the lab and into industrial packaging applications.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/14/2024: Brixton Biosciences venture capital transaction
Next: 5/14/2024: Finlocker venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








